clarithromycin has been researched along with Infections, Respiratory in 159 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (8.81) | 18.7374 |
| 1990's | 45 (28.30) | 18.2507 |
| 2000's | 56 (35.22) | 29.6817 |
| 2010's | 40 (25.16) | 24.3611 |
| 2020's | 4 (2.52) | 2.80 |
| Authors | Studies |
|---|---|
| Agouridas, C; Auger, JM; Benedetti, Y; Bonnefoy, A; Bretin, F; Chantot, JF; D'Ambrières, SG; Denis, A; Dussarat, A; Fromentin, C; Lachaud, S; Laurin, P; Le Martret, O; Loyau, V; Tessot, N | 1 |
| Alder, J; Brazzale, A; Cao, Z; Chu, DT; Clark, RF; Ewing, P; Flamm, R; Griesgraber, G; Li, L; Ma, Z; Meulbroek, J; Mitten, M; Nemoto, PA; Nilius, AM; Or, YS; Phan, LT; Plattner, JJ; Rupp, MJ; Shortridge, VD; Wang, S; Yong, H; Zhang, S; Zhang, X; Zhong, P | 1 |
| Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
| Baba, S; Billal, DS; Fujihara, K; Hotomi, M; Nishimura, T; Suzuki, K; Yamanaka, N | 1 |
| Blackman Northwood, J; Coley, MD; Cossins, LR; Creti, R; Del Grosso, M; Farrell, DJ; Pantosti, A | 1 |
| Li, W; Liu, Y; Wang, M; Xu, X; Ye, X; Zhang, H; Zhu, D | 1 |
| Chen, XZ; Jin, ZP; Lei, PS; Li, Y; Liu, J; Liu, L; Wang, GQ; Xu, P | 1 |
| Buzon, RA; Chupak, L; Dougherty, TJ; Falcone, MJ; Farley, KA; Finegan, SM; Flanagan, ME; Girard, D; Granskog, K; Hagen, AE; Hardink, JR; Huband, MD; Kamicker, BJ; Kaneko, T; Knickerbocker, MJ; Li, B; Liras, JL; Magee, TV; Marra, A; Medina, I; Nguyen, TT; Noe, MC; O'Donnell, JP; Obach, RS; Penzien, JB; Reilly, UD; Ripp, SL; Schafer, JR; Shen, Y; Stone, GG; Strelevitz, TJ; Sun, J; Tait-Kamradt, A; Vaz, AD; Whipple, DA; Widlicka, DW; Wishka, DG; Wolkowski, JP | 1 |
| Bae, S; Kang, Y; Kim, E; Lee, J; Lee, S; Yu, J | 1 |
| Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
| Bhateja, P; Chakrabarti, A; Das, B; Dullu, J; Hajare, AK; Jadhav, JS; Kumar, R; Pandya, M; Ramkumar, G; Rathy, S; Surase, YB; Venkataramanan, R | 1 |
| Kaneda, Y; Manaka, A; Nanaumi, K; Shimazaki, Y; Sugimoto, T; Sugiyama, H; Suzuki, K; Tanikawa, T; Yamasaki, Y | 1 |
| Sugimoto, T; Suzuki, K; Tanikawa, T; Yamasaki, Y | 1 |
| Inagaki, H; Kitamura, T; Komoriya, S; Kuroyanagi, J; Miyauchi, RN; Nagamochi, M; Odagiri, T; Sugimoto, Y; Takahashi, H | 1 |
| Crumrine, M; Hewitt, JA; Slay, RM | 1 |
| Adachi, Y; Hayashi, S; Kagawa, T; Kobayashi, T; Kurahara, Y; Suzuki, K; Tsuyuguchi, K; Yoshida, S | 1 |
| Ashcroft, DM; Brown, B; Li, Y; Palin, V; van Staa, TP; Welfare, W | 1 |
| Bivan, S; Govindarajan, S | 1 |
| DaCosta, A; Esther, CR; Giddings, O; Gilligan, P; Jordan, CL; Lin, FC | 1 |
| Adam, HJ; Baxter, MR; Demczuk, W; Gilmour, MW; Golden, AR; Hoban, DJ; Karlowsky, JA; Martin, I; Mulvey, MR; Nichol, KA; Zhanel, GG | 1 |
| Andersen, ÅB; Gynthersen, R; Katzenstein, TL; Qvist, T | 1 |
| Amighi, K; Pilcer, G; Rosière, R; Sebti, T; Traina, K; Vanderbist, F | 1 |
| Jin, YH; Li, XM; Wang, FC; Yang, F | 1 |
| Howard, ST | 1 |
| Derendorf, H; Ikawa, K; Kikuchi, E; Kikuchi, J; Morikawa, N; Nishimura, M | 1 |
| Arikawa, K; Harada, T; Hayashi, S; Iwamoto, T; Kurashima, A; Nagai, H; Suzuki, K; Tsuyuguchi, K; Yoshida, S | 1 |
| Cao, B; Chen, R; Du, Y; Hu, B; Hu, Y; Liu, Y; Liu, Z; Su, D; Sun, H; Wang, H; Wang, Z; Xu, X; Zhang, F; Zhang, R; Zhao, C; Zhuo, C | 1 |
| Aguado, JM; Delgado, JF; Fernández-Ruiz, M; López-Medrano, F; Ruiz-Cano, MJ; San-Juan, R; Silva, JT | 1 |
| de Souza Carvalho-Wodarz, C; Dimer, F; Hartmann, R; Haupenthal, J; Lehr, CM | 1 |
| Altboum, Z; Bar-David, E; Glinert, I; Kobiler, D; Levy, H; Schlomovitz, J; Sittner, A; Weiss, S | 1 |
| Chan, EW; Chui, CS; Douglas, IJ; Ghebremichael-Weldeselassie, Y; Root, A; Siu, CW; Smeeth, L; Wong, AY; Wong, IC | 1 |
| Alexander, GC; Iyer, G | 2 |
| Chen, L; Chen, X; Jia, X; Li, N; Liu, W; Sun, H; Tong, H; Xiang, R; Xu, Y; Zhang, F; Zhang, J; Zhao, H | 1 |
| Blake, Z | 1 |
| Wong, IC | 1 |
| Arita, M; Furuta, K; Hashimoto, T; Ishida, T; Ito, A; Ito, Y; Sone, N; Tachibana, H; Takaiwa, T; Yokoyama, T | 1 |
| Andréjak, C; Chabot, F; Godbert, B; Hermann, J; Huet, D; Zordan, JM | 1 |
| Cambau, E; Guglielmetti, L; Mougari, F; Raskine, L; Sermet-Gaudelus, I; Veziris, N | 1 |
| Gbinigie, II; Lasserson, D | 1 |
| Bannister, CA; Berni, E; Butler, CC; Currie, CJ; de Voogd, H; Halcox, JP; Jenkins-Jones, S; Jones, B; Ouwens, M | 1 |
| Grobusch, MP; Henning, M; Hira, M; Mithal, Y; Parshotam, K; Rabie, W; Ramdas, Z; Schoeman, HS; Singh, S; Snyman, JR | 1 |
| Oswald, S; Peters, J; Siegmund, W; Venner, M | 1 |
| Alffenaar, JW; Uges, DR; van der Elst, KC | 1 |
| Florou, V; Fragkos, M; Hajiioannou, JK; Kousoulis, P; Moshovakis, E | 1 |
| Boyanova, L; Davidkov, L; Gergova, G; Ilieva, J; Kamburov, V; Katsarov, N; Mitov, I; Spassova, Z | 1 |
| Fitting, JW; Greub, G; Jaton, K; Senn, L | 1 |
| Aberle, T; Aksentijevich, I; Bane, BL; Harley, JB; Thanou-Stavraki, A | 1 |
| Chono, S; Morimoto, K; Togami, K | 2 |
| Ding, FM; Jiang, YQ; Shen, C; Zhu, SL | 1 |
| Cash, HL; Fujita, J | 1 |
| Hosogaya, N; Imamura, Y; Ishimatu, Y; Izumikawa, K; Kakeya, H; Kohno, S; Miyazaki, T; Morinaga, Y; Nakamura, S; Sakamoto, N; Yamamoto, Y; Yanagihara, K; Yasuoka, A | 1 |
| Sugiyama, Y | 1 |
| Maeda, K; Mikasa, K | 1 |
| Odagiri, S; Shimada, J; Takahashi, H; Watanuki, Y | 1 |
| Abad-Santos, F; Espinosa de los Monteros, MJ; Gallego-Sandín, S; Gálvez-Múgica, MA; Novalbos, J | 1 |
| Darkes, MJ; Perry, CM | 1 |
| Abad-Santos, F; Espinosa de los Monteros, MJ; Gallego Sandín, S; Gálvez-Múgica, MA; Novalbos, J | 1 |
| Colombo, A; De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
| Anzueto, A; Norris, S | 1 |
| Scheinfeld, NS; Torres, O; Tutrone, WD; Weinberg, JM | 1 |
| Budanov, SV; Vasil'ev, AN | 1 |
| Arias, M; Rodrigo, E; Valero, R; Zubimendi, JA | 1 |
| Emmett, L; Perera, C; Thanakrishnan, K; Trieu, J; Van Der Wall, H | 1 |
| Amsden, GW | 1 |
| Kadota, J; Kishi, K; Mizunoe, S; Nagai, H; Nasu, M; Tokimatsu, I | 1 |
| Ebisawa, K; Ishida, H; Kakoi, H; Kure, H; Kure, M; Saitoh, H; Takemura, Y | 1 |
| Kardas, P; Muras, M | 1 |
| Asano, K; Gyo, H; Heisha, Y; Higashiyama, Y; Kaneko, Y; Kawano, S; Miyazaki, Y; Monda, J; Ono, H; Tashiro, T; Yanagihara, K | 1 |
| Andreu Rodríguez, AL; Bertomeu Martínez, V; Díaz García, MJ; Morillas Blasco, P | 1 |
| Bishai, WR; Williams, KN | 1 |
| Jaber, BL; Lobon, LF; Madias, NE | 1 |
| D'Ambrosi, M; Giannattasio, A; Iorio, R; Volpicelli, M | 1 |
| Petrini, B | 1 |
| Galanakis, E; Germanakis, I; Kalmanti, M; Parthenakis, F; Vardas, PE | 1 |
| Cifaldi, MA; Halpern, MT; Schmier, JK | 1 |
| Hoban, DJ; Zhanel, GG | 1 |
| Higashiyama, Y; Higuchi, N; Hirakata, Y; Kadota, J; Kohno, S; Kuroki, M; Miyazaki, Y; Mizuta, Y; Mukae, H; Ohno, H; Tomono, K; Tsukamoto, K; Yanagihara, K | 1 |
| Bolay, H; Ozsoylar, G; Sayin, A | 1 |
| Chantzi, F; Kafetzis, DA; Skevaki, CL; Tigani, G | 1 |
| Altraja, A; Kullamaa, A; Leesik, H; Meriste, S; Naaber, P; Tamm, E | 1 |
| Hosoya, M; Katayose, M; Kato, K; Kawasaki, Y; Matsumoto, A; Suzuki, H | 1 |
| Basile, V; Capone, D; Federico, S; Gentile, A; Palmiero, G; Perfetti, A; Pieri, M; Potenza, M; Sabbatini, M; Tarantino, G | 1 |
| De Vecchi, E; Drago, L; Larosa, M; Nicola, L | 1 |
| Konno, K; Tagaya, E; Takeyama, K; Tamaoki, J | 1 |
| Kaye, KM; Zuckerman, JM | 1 |
| Barry, AL; Brown, SD; Fuchs, PC | 2 |
| Hasegawa, N; Kanazawa, M; Kawashiro, T; Sakamaki, F; Terashima, T | 1 |
| Chau, CH; Lee, J; Leung, CW; Yew, WW | 1 |
| Ohgaki, N | 1 |
| Chick, TW; Neu, HC | 1 |
| Coles, SJ; Humphreys, JE; Smith, EG | 1 |
| Alpern, HD; Foltzer, MA; Guiney, WB; Wager, GC | 1 |
| Coles, SJ; James, I; Kearsley, NJ; Macklin, JL | 1 |
| Müller, O | 1 |
| Bradbury, F | 1 |
| Odagiri, S | 1 |
| MacConnachie, AM | 1 |
| Abdel-Rahman, SM; Nahata, MC; Wintermeyer, SM | 1 |
| Gard, P; Guion, A; MacFarlane, JT; Prewitt, J | 1 |
| McCracken, GH | 1 |
| Brogden, RN; Langtry, HD | 1 |
| Vagliasindi, M | 1 |
| Kahn, J; Mauriz, Y; Ogilvie, P; Thornsberry, C | 1 |
| Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
| Anagnostopoulou, M; Boulbasakos, G; Paniara, O; Pirounaki, M; Platsouka, E; Raptis, J; Saroglou, G; Sioula, E; Tatsis, G; Tsoukalas, G | 1 |
| Asano, K; Hirakata, Y; Kadota, J; Kawano, S; Koga, H; Ogawa, K; Ono, H; Sawai, T; Shirai, R; Tashiro, T; Yamamoto, Y; Yanagihara, K | 1 |
| Gunawan, J; Mangunnegoro, H; Soepandi, P; Yunus, F | 1 |
| Denys, A | 1 |
| Berry, V; Knott, SJ; Thorburn, CE; Woodnutt, G | 1 |
| Hashimoto, T; Hayashi, Y; Ikeda, U; Mitsuhashi, T; Shimada, K; Watanabe, T | 1 |
| Carbon, C; Poole, MD | 1 |
| Bocheńska-Marciniak, M; Krzywiecki, A; Kuna, P; Kupryś, I; Sliwowski, A | 1 |
| Agatsuma, Y; Chiba, S; Hiraki, M; Kogasaka, R; Kuniya, Y; Miua, J; Numazaki, K; Sakamoto, Y; Sato, T; Ueda, D; Ukae, S; Umetsu, M; Yamanaka, T | 1 |
| Benjamin, W; Crain, M; Edwards, K; Gray, B; Johnson, C; Waites, K | 1 |
| Higashiyama, Y; Hirakata, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Maesaki, S; Miyazaki, Y; Ohno, H; Sawai, T; Tashiro, T; Tomono, K; Yanagihara, K | 1 |
| Barrett, SP; Guyot, A; Rawlins, MD | 1 |
| Alván, G; Barkholt, L; Edlund, C; Nord, CE; Vacheron, F | 1 |
| Asaoka, N; Honda, Y; Ohba, H; Okimoto, N; Osaki, K; Soejima, R; Sunagawa, T; Yoneyama, H | 1 |
| Garanina, TA; Iakovlev, VP; Khlebnikov, EP; Pavlova, MB | 1 |
| Wilcox, MH | 1 |
| Adam, D; Brueckner, OJ; Glaser-Caldow, E; Hein, J; Hirsch, J; Kroemer, B; Wachter, J | 1 |
| Asherov, J; Dan, M; Poch, F | 1 |
| Carabias, ML; Cervera, LA; entelles, ML; García-Navas, BL | 1 |
| Allin, D; Carr, W; Coles, S; Cullen, S; James, I; Lytle, T; Middleton, A; Newson, P; Zachariah, J | 1 |
| Garcia-Motos, C; Martínez-Ramírez, M; Montesinos-Ros, A; Navarro-Ruiz, A; Sendra, P | 1 |
| Christopher, K; Horkan, C; Hyatt, PA; Yodice, PC | 1 |
| Hirakata, Y; Imamura, Y; Kadota, J; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Mukae, H; Sawai, T; Tomono, K; Yanagihara, K | 1 |
| Aiolfi, S; Beghi, G; Patruno, V | 1 |
| Havlichek, DH; Stein, GE | 1 |
| Tunkel, AR; Whitman, MS | 1 |
| Stott, GA | 1 |
| Peltier, K | 1 |
| Hamada, K; Kita, E; Konishi, M; Kunimatsu, M; Maeda, K; Masutani, T; Mikasa, K; Sano, R; Sawaki, M; Takeuchi, S | 1 |
| Rapp, RP; Sturgill, MG | 1 |
| Guay, DR; Hardy, DJ; Jones, RN | 1 |
| Chonmaitree, T; Hedgpeth, D; Horlick, D; Howie, VM; Owen, MJ; Patel, JA | 1 |
| Anderson, G | 1 |
| Bachand, RT; Coles, SJ; Millar, ED; O'Neill, SJ | 1 |
| Akita, H; Iwata, S; Sato, Y; Sunakawa, K | 1 |
| Iwai, N; Kasai, K; Miyazu, M; Nakamura, H; Taneda, Y | 1 |
| Hayakawa, F; Ishikawa, H; Kimura, H; Kuno, K; Nakao, Y; Takeuchi, H; Yamamoto, N | 1 |
| Iguchi, K; Kamiya, H; Kawaguchi, H; Sakurai, M | 1 |
| Ito, S; Mayumi, M; Mikawa, H | 1 |
| Aoki, S; Nishimura, T; Tabuki, K; Takagi, M | 1 |
| Haruta, T; Kobayashi, Y; Kuroki, S; Ohkura, K; Tsutsui, T | 1 |
| Adachi, Y; Hattori, K; Higashino, H; Kobayashi, Y; Nobori, U; Sato, Y; Takebe, A; Takedatsu, M; Tanaka, H; Uh, M | 1 |
| Hosoda, T; Ichioka, T; Miyao, M; Tayama, M | 1 |
| Hayashi, M; Kida, K; Matsuda, H; Murase, M | 1 |
| Araki, K; Kubota, H; Kurashige, T; Nomura, I; Ogura, H; Ogura, Y; Tomoda, T | 1 |
| Kozan, S; Miyazaki, M; Nishimori, M; Ohara, K; Okamoto, T; Sekiguchi, T | 1 |
| Imamura, H; Nakayama, N; Tsuji, Y; Yanagi, T; Yanagishima, M; Yanai, M | 1 |
| Jansson, L; Kalin, M | 1 |
29 review(s) available for clarithromycin and Infections, Respiratory
| Article | Year |
|---|---|
Telithromycin versus clarithromycin for the treatment of community-acquired respiratory tract infections: a meta-analysis of randomized controlled trials.
Topics: Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Humans; Ketolides; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2013 |
Mycobacterium abscessus pulmonary infection complicated with vertebral osteomyelitis in a heart transplant recipient: case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Female; Heart Transplantation; Humans; Immunocompromised Host; Mycobacterium; Osteomyelitis; Respiratory Tract Infections; Risk Factors; Treatment Outcome | 2015 |
Infections caused by Mycobacterium abscessus: epidemiology, diagnostic tools and treatment.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Humans; Mycobacterium; Mycobacterium Infections; Prevalence; Respiratory Tract Infections; Treatment Outcome; Virulence | 2016 |
[Contribution of Japanese researchers to progress in the field of pulmonary medicine in the last 100 years: New pharmacological action of macrolides].
Topics: Anti-Bacterial Agents; Azithromycin; Bronchiolitis; Chronic Disease; Clarithromycin; Erythromycin; History, 20th Century; Humans; Japan; Lung Neoplasms; Respiratory Tract Infections | 2002 |
[Meta-analysis of clarithromycin compared with other antimicrobial drugs in the treatment of upper respiratory tract infections].
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Humans; Respiratory Tract Infections | 2003 |
Clarithromycin extended-release tablet: a review of its use in the management of respiratory tract infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Biological Availability; Clarithromycin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Microbial Sensitivity Tests; Randomized Controlled Trials as Topic; Respiratory Tract Infections; Tablets; Treatment Outcome | 2003 |
[Meta-analysis of clarithromycin compared to other antibiotics for the treatment of lower respiratory tract infections].
Topics: Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Humans; Respiratory Tract Infections | 2003 |
Clarithromycin in 2003: sustained efficacy and safety in an era of rising antibiotic resistance.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Humans; Respiratory Tract Infections | 2004 |
Macrolides in dermatology.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Biological Availability; Child; Clarithromycin; Clinical Trials as Topic; Half-Life; Humans; Intestinal Absorption; Macrolides; Respiratory Tract Infections; Skin Diseases, Bacterial | 2004 |
[Clarithromycin: specific features of antimicrobial spectrum and clinical use].
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Respiratory Tract Infections | 2004 |
Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Azithromycin; Chronic Disease; Clarithromycin; Community-Acquired Infections; Erythromycin; Humans; Inflammation; Macrolides; Respiratory Tract Infections | 2005 |
Clarithromycin extended-release in community-acquired respiratory tract infections.
Topics: Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Drug Administration Schedule; Humans; Respiratory Tract Infections | 2005 |
Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Respiratory Tract Infections; Skin; Soft Tissue Infections; Species Specificity; Surgical Wound Infection; Tigecycline; Tuberculosis, Cutaneous; Wounds and Injuries | 2006 |
Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Risk Factors; Streptococcus pneumoniae | 2006 |
The newer macrolides. Azithromycin and clarithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Humans; Respiratory Tract Infections | 1995 |
Pulmonary infection due to Mycobacterium xenopi.
Topics: Bacterial Typing Techniques; Clarithromycin; Cycloserine; DNA Probes; Drug Resistance, Microbial; Gastrectomy; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium Infections; Respiratory Tract Infections; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1994 |
Dirithromycin: a new macrolide.
Topics: Anti-Bacterial Agents; Azithromycin; Bacteria, Anaerobic; Clarithromycin; Drug Interactions; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Macrolides; Respiratory Tract Infections | 1996 |
Microbiologic activity of the newer macrolide antibiotics.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Ear, Middle; Erythromycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests; Penicillin Resistance; Respiratory Tract Infections; Streptococcal Infections; Streptococcus pneumoniae | 1997 |
Clarithromycin. A review of its efficacy in the treatment of respiratory tract infections in immunocompetent patients.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Child; Clarithromycin; Drug Interactions; Humans; Immunocompetence; Respiratory Tract Infections | 1997 |
[Theoretical basis for the antibiotic therapy of the upper part of the respiratory system].
Topics: Anti-Bacterial Agents; Clarithromycin; Humans; Respiratory Tract Infections | 1997 |
The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Community-Acquired Infections; Drug Resistance, Microbial; Global Health; Humans; Respiratory Tract Infections | 1999 |
Hallucinations with therapeutic doses of clarithromycin.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anxiety; Clarithromycin; Dizziness; Female; Hallucinations; Humans; Respiratory Tract Infections | 2002 |
The new macrolide antibiotics. Azithromycin and clarithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Clinical Protocols; Clinical Trials as Topic; Drug Resistance, Microbial; Erythromycin; Humans; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious; Therapeutic Equivalency | 1992 |
Azithromycin and clarithromycin: overview and comparison with erythromycin.
Topics: Azithromycin; Bacterial Infections; Clarithromycin; Erythromycin; Gram-Negative Bacterial Infections; Humans; In Vitro Techniques; Mycobacterium Infections, Nontuberculous; Respiratory Tract Infections; Sexually Transmitted Diseases; Skin Diseases, Infectious | 1992 |
New macrolide antibiotics: clarithromycin and azithromycin.
Topics: Azithromycin; Clarithromycin; Erythromycin; Humans; Respiratory Tract Infections; Skin Diseases, Infectious | 1992 |
The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
Topics: Azithromycin; Clarithromycin; Drug Interactions; Erythromycin; Humans; Respiratory Tract Infections | 1992 |
Clarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Drug Interactions; Erythromycin; Humans; Macrophages; Mycobacterium avium-intracellulare Infection; Respiratory Tract Infections; Skin Diseases, Infectious | 1992 |
Clarithromycin, a unique macrolide. A pharmacokinetic, microbiological, and clinical overview.
Topics: Clarithromycin; Erythromycin; Humans; Respiratory Tract Infections; Skin Diseases, Infectious | 1992 |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
Topics: Administration, Oral; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Gastrointestinal Diseases; Humans; Incidence; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1991 |
24 trial(s) available for clarithromycin and Infections, Respiratory
| Article | Year |
|---|---|
Generic versus non-generic formulation of extended-release clarithromycin in patients with community-acquired respiratory tract infections: a prospective, randomized, comparative, investigator-blind, multicentre study.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drugs, Generic; Female; Humans; Male; Prospective Studies; Respiratory Tract Infections; Single-Blind Method; Therapeutic Equivalency; Treatment Outcome | 2009 |
LC-MS/MS method for the simultaneous determination of clarithromycin, rifampicin and their main metabolites in horse plasma, epithelial lining fluid and broncho-alveolar cells.
Topics: Animals; Anti-Bacterial Agents; Biotransformation; Bronchioles; Bronchoalveolar Lavage Fluid; Chromatography, High Pressure Liquid; Clarithromycin; Drug Interactions; Drug Stability; Horse Diseases; Horses; Limit of Detection; Pulmonary Alveoli; Reproducibility of Results; Respiratory Tract Infections; Rifampin; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |
Antibiotic selection patterns in acutely febrile new outpatients with or without immediate testing for C reactive protein and leucocyte count.
Topics: Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Biomarkers; C-Reactive Protein; Cephalosporins; Clarithromycin; Fever; Humans; Japan; Leukocyte Count; Middle Aged; Outpatient Clinics, Hospital; Practice Patterns, Physicians'; Respiratory Tract Infections; Treatment Outcome | 2005 |
Clarithromycin treatment and QT prolongation in childhood.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Electrocardiography; Female; Humans; Infant; Long QT Syndrome; Male; Respiratory Tract Infections | 2006 |
Effect of clarithromycin on sputum production and its rheological properties in chronic respiratory tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bronchiolitis; Bronchitis; Chronic Disease; Clarithromycin; Colony Count, Microbial; Double-Blind Method; Elasticity; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Rheology; Sputum; Viscosity | 1995 |
Efficacy and safety of clarithromycin compared to cefixime as outpatient treatment of lower respiratory tract infections.
Topics: Adult; Aged; Ambulatory Care; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Cefixime; Cefotaxime; Clarithromycin; Community-Acquired Infections; Double-Blind Method; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Respiratory Tract Infections; United States | 1993 |
A single-blind, randomised, comparative study of clarithromycin and amoxycillin suspensions in the treatment of children with lower respiratory tract infections.
Topics: Amoxicillin; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Female; Humans; Infant; Male; Respiratory Tract Infections; Single-Blind Method; Suspensions | 1993 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Child; Clarithromycin; Drug Administration Schedule; Erythromycin; Escherichia coli Infections; Female; Humans; Male; Middle Aged; Otitis Media; Pharyngitis; Respiratory Tract Infections; Sinusitis; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1993 |
Comparison of azithromycin versus clarithromycin in the treatment of patients with lower respiratory tract infection.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Bacterial Infections; Bronchitis; Clarithromycin; Drug Administration Schedule; Erythromycin; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections | 1993 |
Comparison of amoxycillin and clarithromycin as initial treatment of community-acquired lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Penicillins; Respiratory Tract Infections; Single-Blind Method | 1996 |
Use of flurythromycin ethylsuccinate in infections of lower airways due to sensitive germs: multicenter comparative study with clarithromycin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Clarithromycin; Culture Media; Double-Blind Method; Erythromycin; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Reference Standards; Respiratory Tract Infections | 1997 |
Efficacy and tolerance of roxithromycin versus clarithromycin in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Respiratory Tract Infections; Roxithromycin | 1998 |
The pattern of micro-organisms and the efficacy of new macrolide in acute lower respiratory tract infections.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Azithromycin; Bronchitis; Clarithromycin; Female; Humans; Klebsiella pneumoniae; Male; Pneumonia; Respiratory Tract Infections; Specimen Handling; Sputum; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 1998 |
[Clinical efficacy and safety of spiramycin and clarithromycin in the treatment of outpatients with lower respiratory tract infections].
Topics: Adult; Aged; Ambulatory Care; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Male; Middle Aged; Monitoring, Physiologic; Respiratory Function Tests; Respiratory Tract Infections; Spiramycin; Treatment Outcome | 1998 |
Therapeutic effect of clarithromycin for respiratory-tract infections in children caused by Chlamydia pneumoniae. Research Group of Sapporo for Pediatric Chlamydial Infections.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Humans; Infant; Infant, Newborn; Pneumonia, Mycoplasma; Respiratory Tract Infections | 2000 |
Pharmacokinetics and comparative effects of telithromycin (HMR 3647) and clarithromycin on the oropharyngeal and intestinal microflora.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Area Under Curve; Bacteroides; Clarithromycin; Double-Blind Method; Feces; Female; Humans; Intestines; Ketolides; Macrolides; Male; Microbial Sensitivity Tests; Oropharynx; Respiratory Tract Infections; Saliva; Statistics, Nonparametric | 2000 |
[Macrolide antibiotic clarithromycin (Klabax) in treatment of community-acquired respiratory tract infections].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bronchitis; Bronchopneumonia; Clarithromycin; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pharyngitis; Respiratory Tract Infections; Tonsillitis | 2000 |
Comparative efficacy of clarithromycin modified-release and clarithromycin immediate-release formulations in the treatment of lower respiratory tract infection.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Chemistry, Pharmaceutical; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Treatment Outcome | 2001 |
Crossover assessment of serum bactericidal activity of grepafloxacin, ofloxacin and clarithromycin against respiratory pathogens after oral administration to healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Blood Bactericidal Activity; Clarithromycin; Cross-Over Studies; Female; Fluoroquinolones; Haemophilus influenzae; Humans; In Vitro Techniques; Klebsiella pneumoniae; Male; Moraxella catarrhalis; Ofloxacin; Penicillin Resistance; Piperazines; Respiratory Tract Infections; Streptococcus pneumoniae | 2001 |
Comparison of once- and twice-daily clarithromycin in the treatment of adults with severe acute lower respiratory tract infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Treatment Outcome | 2001 |
[Clarithromycin switch therapy in adult patients suffering from community-acquired lower respiratory tract infections (LRTIs) requiring hospitalisation].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Community-Acquired Infections; Female; Hospitalization; Humans; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections | 2001 |
Effect of viral respiratory tract infection on outcome of acute otitis media.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefpodoxime; Ceftizoxime; Clarithromycin; Clavulanic Acids; Drug Therapy, Combination; Erythromycin; Female; Humans; Infant; Male; Otitis Media; Respiratory Tract Infections; Treatment Outcome; Virus Diseases | 1992 |
Clarithromycin in the treatment of community-acquired lower respiratory tract infections.
Topics: Administration, Oral; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Gastrointestinal Diseases; Humans; Incidence; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1991 |
Safety and efficacy of Clarithromycin in the treatment of acute mild to moderate respiratory tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Clarithromycin; Erythromycin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1991 |
107 other study(ies) available for clarithromycin and Infections, Respiratory
| Article | Year |
|---|---|
Synthesis and antibacterial activity of ketolides (6-O-methyl-3-oxoerythromycin derivatives): a new class of antibacterials highly potent against macrolide-resistant and -susceptible respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Crystallography, X-Ray; Drug Evaluation, Preclinical; Drug Resistance, Microbial; Drug Resistance, Multiple; Enterococcus; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Ketolides; Macrolides; Male; Mice; Models, Molecular; Molecular Conformation; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus; Streptococcus; Streptococcus pneumoniae | 1998 |
Novel erythromycin derivatives with aryl groups tethered to the C-6 position are potent protein synthesis inhibitors and active against multidrug-resistant respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cell-Free System; Drug Resistance, Multiple; Erythromycin; Haemophilus influenzae; Ketolides; Lung; Mice; Models, Molecular; Protein Biosynthesis; Protein Synthesis Inhibitors; Rats; Respiratory Tract Infections; Ribosomes; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship; Transcription, Genetic | 2001 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan.
Topics: Adolescent; Adult; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Child; Child, Preschool; Female; Gene Frequency; Genotype; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Respiratory Tract Infections | 2007 |
Characterization of macrolide efflux pump mef subclasses detected in clinical isolates of Streptococcus pyogenes isolated between 1999 and 2005.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Community-Acquired Infections; Drug Resistance, Bacterial; Global Health; Humans; Macrolides; Membrane Proteins; Microbial Sensitivity Tests; Molecular Sequence Data; Population Surveillance; Respiratory Tract Infections; Sequence Analysis, DNA; Streptococcal Infections; Streptococcus pyogenes | 2009 |
Antimicrobial susceptibility of Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant strains from Shanghai, China.
Topics: Adhesins, Bacterial; Anti-Bacterial Agents; Child; China; Drug Resistance, Bacterial; Genes, rRNA; Humans; Macrolides; Microbial Sensitivity Tests; Mutation; Mycoplasma pneumoniae; Pneumonia, Mycoplasma; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Respiratory Tract Infections; RNA, Ribosomal, 23S; Sequence Analysis, DNA | 2009 |
Synthesis of novel macrolide derivatives with imidazo[4,5-b]pyridinyl sulfur contained alkyl side chains and their antibacterial activity.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Design; Drug Resistance, Multiple, Bacterial; Erythromycin; Humans; Imidazoles; Ketolides; Macrolides; Microbial Sensitivity Tests; Models, Chemical; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Sulfides; Sulfur | 2009 |
Discovery of azetidinyl ketolides for the treatment of susceptible and multidrug resistant community-acquired respiratory tract infections.
Topics: Animals; Azetidines; Bacteria; Community-Acquired Infections; Disease Susceptibility; Drug Discovery; Drug Resistance, Multiple; Drug-Related Side Effects and Adverse Reactions; Humans; Ketolides; Mice; Microbial Sensitivity Tests; Respiratory Tract Infections | 2009 |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Ampicillin Resistance; beta-Lactamases; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillin-Binding Proteins; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Serotyping; Young Adult | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
Synthesis and antibacterial activity of a novel series of acylides active against community acquired respiratory pathogens.
Topics: Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clarithromycin; Drug Design; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Models, Chemical; Nitrogen; Respiratory Tract Infections; Streptococcus pneumoniae | 2012 |
Synthesis and antibacterial activity of 6-O-(heteroaryl-isoxazolyl)propynyl 2-fluoro ketolides.
Topics: Anti-Bacterial Agents; Crystallography, X-Ray; Drug Resistance, Bacterial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Halogenation; Humans; Ketolides; Microbial Sensitivity Tests; Models, Molecular; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus | 2012 |
Synthesis and structure-activity relationship of a novel class of 15-membered macrolide antibiotics known as '11a-azalides'.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Humans; Macrolides; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Structure-Activity Relationship | 2012 |
Design, synthesis, and biological evaluations of novel 7-[7-amino-7-methyl-5-azaspiro[2.4]heptan-5-yl]-8-methoxyquinolines with potent antibacterial activity against respiratory pathogens.
Topics: Animals; Anti-Bacterial Agents; Drug Design; Fluoroquinolones; Haemophilus influenzae; Male; Mice; Microbial Sensitivity Tests; Quinolones; Rats; Respiratory Tract Infections; Spiro Compounds; Staphylococcus aureus; Streptococcus pneumoniae | 2013 |
Determination of the Postexposure Prophylactic Benefit of Oral Azithromycin and Clarithromycin Against Inhalation Anthrax in Cynomolgus Macaques.
Topics: Animals; Anthrax; Anti-Bacterial Agents; Azithromycin; Bacillus anthracis; Clarithromycin; Disease Models, Animal; Levofloxacin; Macaca fascicularis; Respiratory Tract Infections | 2022 |
Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prognosis; Respiratory Tract Infections; Retrospective Studies; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
The Safety of Delayed Versus Immediate Antibiotic Prescribing for Upper Respiratory Tract Infections.
Topics: Anti-Bacterial Agents; Clarithromycin; Doxycycline; Erythromycin; Humans; Inappropriate Prescribing; Practice Patterns, Physicians'; Respiratory Tract Infections | 2021 |
Viral and bacterial coinfection of the respiratory tract in a 10-month-old child.
Topics: Adenoviridae Infections; Anti-Bacterial Agents; Bordetella Infections; Clarithromycin; Coinfection; Female; Fluid Therapy; Hospitalization; Humans; Infant; Multiplex Polymerase Chain Reaction; Nasopharynx; Oxygen Inhalation Therapy; Radiography; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Treatment Outcome | 2020 |
Outcomes associated with antibiotic regimens for treatment of Mycobacterium abscessus in cystic fibrosis patients.
Topics: Adolescent; Anti-Bacterial Agents; Child; Clarithromycin; Cystic Fibrosis; Drug Monitoring; Female; Humans; Male; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Respiratory Function Tests; Respiratory Tract Infections; Retrospective Studies; Sputum; Treatment Outcome; United States | 2017 |
Antimicrobial susceptibility testing of invasive isolates of Streptococcus pneumoniae from Canadian patients: the SAVE study, 2011-15.
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Bacterial Agents; Canada; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Risk Factors; Streptococcus pneumoniae; Young Adult | 2018 |
Mycobacterium brisbanense lung infection facilitated by steroid induced adrenal insufficiency.
Topics: Adrenal Insufficiency; Adult; Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Humans; Male; Moxifloxacin; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Sputum | 2019 |
New co-spray-dried tobramycin nanoparticles-clarithromycin inhaled powder systems for lung infection therapy in cystic fibrosis patients.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Clarithromycin; Cystic Fibrosis; Desiccation; Drug Delivery Systems; Humans; Lung; Lung Diseases; Nanoparticles; Powders; Respiratory Tract Infections; Solubility; Tobramycin | 2013 |
Recent progress towards understanding genetic variation in the Mycobacterium abscessus complex.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Female; Genetic Variation; Host-Pathogen Interactions; Humans; Lung; Male; Mycobacterium; Mycobacterium Infections, Nontuberculous; Phylogeny; Respiratory Tract Infections; Sequence Analysis, DNA; Soft Tissue Infections; Virulence | 2013 |
Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages.
Topics: Anti-Bacterial Agents; Area Under Curve; Bacteria; Bronchi; Clarithromycin; Computer Simulation; Dose-Response Relationship, Drug; Epithelium; Humans; Ketolides; Microbial Sensitivity Tests; Models, Biological; Nonlinear Dynamics; Respiratory Tract Infections; Tissue Distribution | 2014 |
Investigation of the population structure of Mycobacterium abscessus complex strains using 17-locus variable number tandem repeat typing and the further distinction of Mycobacterium massiliense hsp65 genotypes.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chaperonin 60; Clarithromycin; Cluster Analysis; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genetic Variation; Genotype; Humans; Japan; Microbial Sensitivity Tests; Minisatellite Repeats; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Sequence Analysis, DNA | 2015 |
[Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cephalosporins; China; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2015 |
Inhalable Clarithromycin Microparticles for Treatment of Respiratory Infections.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Cell Line; Clarithromycin; Dry Powder Inhalers; Escherichia coli; Escherichia coli Infections; Humans; Particle Size; Respiratory Tract Infections; Solubility; Staphylococcal Infections; Staphylococcus aureus | 2015 |
Efficacy of Single and Combined Antibiotic Treatments of Anthrax in Rabbits.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anthrax; Anti-Bacterial Agents; Bacillus anthracis; Bacteremia; Ciprofloxacin; Clarithromycin; Disease Models, Animal; Doxycycline; Drug Combinations; Drug Synergism; Humans; Imipenem; Linezolid; Male; Microbial Sensitivity Tests; Rabbits; Respiratory Tract Infections; Rifampin; Spores, Bacterial; Survival Analysis; Vancomycin | 2015 |
Cardiovascular outcomes associated with use of clarithromycin: population based study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Middle Aged; Propensity Score; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 2016 |
Cardiovascular risks associated with clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
[Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014].
Topics: Anti-Bacterial Agents; Aza Compounds; Cefepime; Cephalosporins; China; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Fluoroquinolones; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Moxifloxacin; Penicillins; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae | 2016 |
Study provides insufficient evidence of a link between clarithromycin and myocardial infarction.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Editorialists' reply to Blake.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
Author's reply to Blake.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Respiratory Tract Infections | 2016 |
18 Cases of pulmonary Mycobacterium abscessus: Clinical difference depending on the presence or absence of Mycobacterium avium complex.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Confidence Intervals; Female; Follow-Up Studies; Humans; Japan; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Respiratory Tract Infections; Retrospective Studies | 2016 |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment].
Topics: Clarithromycin; Diagnosis, Differential; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Rifampin; Tuberculosis, Pulmonary | 2017 |
Clarithromycin-induced akathisia: a class effect of macrolides?
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Female; Humans; Macrolides; Psychomotor Agitation; Respiratory Tract Infections | 2016 |
Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Arrhythmias, Cardiac; Cardiovascular Diseases; Cause of Death; Clarithromycin; Doxycycline; Erythromycin; Female; Humans; Male; Middle Aged; Respiratory Tract Infections; Risk Factors; United Kingdom | 2017 |
Validation parameters cannot be obtained without using pure substance.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Clarithromycin; Horse Diseases; Pulmonary Alveoli; Respiratory Tract Infections; Rifampin | 2011 |
Clarithromycin induced reversible sensorineural hearing loss.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Female; Follow-Up Studies; Hearing; Hearing Loss, Sensorineural; Humans; Respiratory Tract Infections | 2011 |
Numerous risk factors for Helicobacter pylori antibiotic resistance revealed by extended anamnesis: a Bulgarian study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bulgaria; Clarithromycin; Coinfection; Drug Resistance, Multiple, Bacterial; Female; Health Personnel; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Respiratory Tract Infections; Risk Factors; Socioeconomic Factors; Surveys and Questionnaires; Urinary Tract Infections; Young Adult | 2012 |
Does respiratory infection due to Chlamydia pneumoniae still exist?
Topics: Adolescent; Bacterial Load; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Cough; Diagnosis, Differential; DNA, Bacterial; Female; Humans; Male; Middle Aged; Nasopharynx; Pneumonia, Bacterial; Polymerase Chain Reaction; Respiratory Tract Infections; Sputum | 2011 |
Clarithromycin in adult-onset still's disease: a potentially useful therapeutic.
Topics: Adult; Anti-Bacterial Agents; Clarithromycin; Fasciitis; Female; Humans; Magnetic Resonance Imaging; Panniculitis; Respiratory Tract Infections; Still's Disease, Adult-Onset; Young Adult | 2011 |
Aerosol-based efficient delivery of clarithromycin, a macrolide antimicrobial agent, to lung epithelial lining fluid and alveolar macrophages for treatment of respiratory infections.
Topics: Administration, Inhalation; Administration, Oral; Aerosols; Animals; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Bronchoalveolar Lavage Fluid; Clarithromycin; Drug Delivery Systems; Lung; Macrophages, Alveolar; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Time Factors | 2012 |
Low-dose clarithromycin therapy modulates CD4(+) T-cell responses in a mouse model of chronic Pseudomonas aeruginosa lung infection.
Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage; Clarithromycin; Disease Models, Animal; Female; Immunohistochemistry; Interleukin-17; Interleukin-4; Lung Diseases; Mice; Mice, Inbred BALB C; Pseudomonas aeruginosa; Pseudomonas Infections; Real-Time Polymerase Chain Reaction; Respiratory Tract Infections; Stem Cells; T-Lymphocytes, Regulatory | 2012 |
Long-term combination treatment of azithromycin with other macrolides: a new era.
Topics: Azithromycin; Clarithromycin; Female; Humans; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2012 |
A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Therapy, Combination; Female; Humans; Immunologic Factors; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Treatment Outcome | 2012 |
Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells.
Topics: Adenosine Triphosphatases; Algorithms; Animals; Anti-Bacterial Agents; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azithromycin; Biological Transport, Active; Cell Line; Clarithromycin; Epithelial Cells; Ketolides; Lung; Mice; Multidrug Resistance-Associated Proteins; Protein Binding; Respiratory Tract Infections | 2012 |
[Anti-microbial sensitivities of bacteria isolated from patients with chronic lower respiratory tract infection under long-term macrolide therapy].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Haemophilus influenzae; Humans; Pseudomonas aeruginosa; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
[Epidemiological study on patients with pneumococcal respiratory tract infection in a Japanese health facility during the past year].
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; Chronic Disease; Clarithromycin; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Lactams; Male; Middle Aged; Ofloxacin; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 2001 |
Selection of resistance of telithromycin against Haemophilus influenzae, Moraxella catarrhalis and streptococci in comparison with macrolides.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Gene Frequency; Haemophilus influenzae; Humans; Ketolides; Macrolides; Microbial Sensitivity Tests; Moraxella catarrhalis; Mutation; Respiratory Tract Infections; Streptococcus; Streptococcus pneumoniae | 2004 |
[Rhabdomyolysis secondary to the interaction of statins with macrolides in a renal transplant patient].
Topics: Aged; Anticholesteremic Agents; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Humans; Hyperlipidemias; Inactivation, Metabolic; Kidney Transplantation; Male; Postoperative Complications; Respiratory Tract Infections; Rhabdomyolysis; Simvastatin | 2004 |
Rhabdomyolysis resulting from interaction of simvastatin and clarithromycin demonstrated by Tc-99m MDP scintigraphy.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Interactions; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Radionuclide Imaging; Radiopharmaceuticals; Respiratory Tract Infections; Rhabdomyolysis; Simvastatin; Technetium Tc 99m Medronate | 2004 |
Antibiotic-induced apoptosis in human activated peripheral lymphocytes.
Topics: Annexin A5; Anti-Bacterial Agents; Apoptosis; Azithromycin; Clarithromycin; Humans; Lymphocyte Activation; Lymphocytes; Macrolides; Propidium; Respiratory Tract Infections | 2005 |
[A blinded comparison of palatability of 13 common pediatric antibiotic suspensions].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clarithromycin; Clavulanic Acid; Clindamycin; Double-Blind Method; Female; Humans; Male; Patient Compliance; Pediatrics; Penicillins; Respiratory Tract Infections; Suspensions; Taste; Trimethoprim, Sulfamethoxazole Drug Combination | 2005 |
[Analysis of the mechanism of suppression on MUC5AC by macrolides--an analysis by using a chronic airway infection model].
Topics: Animals; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Disease Models, Animal; Male; Mice; Mucin 5AC; Mucins; Respiratory Tract Infections | 2004 |
[EKG changes in a patient with respiratory infection].
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Electrocardiography; Humans; Long QT Syndrome; Male; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections | 2005 |
The serotonin syndrome complicating co-prescription of paroxetine and clarithromycin.
Topics: Adult; Anti-Bacterial Agents; Antidepressive Agents, Second-Generation; Anxiety; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Drug Prescriptions; Enzyme Inhibitors; Female; Humans; Paroxetine; Respiratory Tract Infections; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome | 2006 |
Steroid therapy for a case of severe drug-induced cholestasis.
Topics: Adolescent; Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Chemical and Drug Induced Liver Injury; Cholestasis; Clarithromycin; Drug Therapy, Combination; Female; Humans; Liver; Liver Function Tests; Respiratory Tract Infections; Sulfonamides | 2006 |
Costs and outcomes of extended-release vs. immediate-release clarithromycin for lower respiratory tract infections.
Topics: Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Decision Support Techniques; Delayed-Action Preparations; Health Care Costs; Humans; Respiratory Tract Infections; Treatment Outcome | 2005 |
Telithromycin inhibits the number of viable bacteria but not lymphocyte accumulation in a murine model of chronic respiratory infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Ketolides; Lung; Lymphocytes; Male; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2007 |
Clarithromycin monotherapy-induced delirium.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Delirium; Humans; Male; Respiratory Tract Infections | 2007 |
Safety and tolerability of clarithromycin administered to children at higher-than-recommended doses.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Female; Greece; Humans; Infant; Male; Respiratory Tract Infections | 2007 |
Antimicrobial susceptibility of common pathogens from community-acquired lower respiratory tract infections in Estonia.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance, Bacterial; Estonia; Female; Haemophilus influenzae; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Middle Aged; Penicillins; Respiratory Tract Infections; Streptococcus pneumoniae | 2006 |
The emergence of drug-resistant Streptococcus pneumoniae and host risk factors for carriage of drug-resistant genes in northeastern Japan.
Topics: Bacterial Proteins; Carrier State; Clarithromycin; Drug Resistance, Bacterial; Erythromycin; Humans; Japan; Membrane Proteins; Meropenem; Microbial Sensitivity Tests; Nasopharynx; Penicillin-Binding Proteins; Penicillins; Respiratory Tract Infections; Risk Factors; Streptococcus pneumoniae; Thienamycins | 2007 |
A pharmacokinetic interaction between clarithromycin and sirolimus in kidney transplant recipient.
Topics: Acute Disease; Anti-Bacterial Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Female; Haemophilus influenzae; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Middle Aged; Respiratory Tract Infections; Sirolimus | 2007 |
In vitro activity of telithromycin against Haemophilus influenzae at epithelial lining fluid concentrations.
Topics: Anti-Bacterial Agents; Azithromycin; beta-Lactamases; Carbon Dioxide; Clarithromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Ketolides; Microbial Sensitivity Tests; Respiratory Tract Infections; Time Factors | 2008 |
Relative potencies of azithromycin, clarithromycin and five other orally administered antibiotics.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 1995 |
[Recent advances in macrolide antibiotics: focused on clarithromycin. Discussion].
Topics: Chronic Disease; Clarithromycin; Humans; Respiratory Tract Infections | 1994 |
Cholestatic hepatitis in a patient who received clarithromycin therapy for a Mycobacterium chelonae lung infection.
Topics: Chemical and Drug Induced Liver Injury; Clarithromycin; Humans; Male; Middle Aged; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Respiratory Tract Infections | 1994 |
Bacterial biofilm in chronic airway infection.
Topics: Animals; Anti-Bacterial Agents; Bacterial Adhesion; Bronchiectasis; Bronchoalveolar Lavage Fluid; Chemotaxis; Chronic Disease; Clarithromycin; Humans; In Vitro Techniques; Lung; Male; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1994 |
A clarithromycin sensitivity survey in the United Kingdom using Stokes' method.
Topics: Clarithromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 1993 |
Bronchopulmonary bacillary angiomatosis.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary; Clarithromycin; Humans; Male; Respiratory Tract Infections | 1993 |
Levofloxacin in patients with severe respiratory tract infection.
Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Asthma; Bronchitis; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pseudomonas aeruginosa; Respiratory Tract Infections | 1995 |
Clarithromycin (klaricid, Abbott).
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Costs; Drug Monitoring; Humans; Respiratory Tract Infections | 1996 |
Macrolide resistance among Streptococcus pneumoniae and Streptococcus pyogenes isolates from out-patients in the USA.
Topics: Anti-Bacterial Agents; Azithromycin; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae; Streptococcus pyogenes; United States | 1997 |
Surveillance of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States in 1996-1997 respiratory season. The Laboratory Investigator Group.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cefuroxime; Clarithromycin; Cohort Studies; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Levofloxacin; Microbial Sensitivity Tests; Moraxella catarrhalis; Ofloxacin; Respiratory Tract Infections; Streptococcus pneumoniae; United States | 1997 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
[Analysis of chronic respiratory tract infection by using an intubation model--evaluation based on fluctuations in cytokine content].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Disease Models, Animal; Intubation, Intratracheal; Male; Mice; Respiratory Tract Infections; Tumor Necrosis Factor-alpha | 1997 |
Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.
Topics: Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Area Under Curve; Azithromycin; Clarithromycin; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Male; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Streptococcus pneumoniae; Time Factors | 1998 |
Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia.
Topics: Aged; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Arrhythmias, Cardiac; Clarithromycin; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Disopyramide; Electrocardiography; Female; Humans; Hypokalemia; Mixed Function Oxygenases; Myocardial Infarction; Respiratory Tract Infections; Torsades de Pointes | 1999 |
Use of clindamycin disks To detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children.
Topics: Adult; Anti-Bacterial Agents; Child; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Humans; Methyltransferases; Microbial Sensitivity Tests; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2000 |
Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation.
Topics: Animals; Biofilms; Chronic Disease; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Intubation; Levofloxacin; Male; Mice; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 2000 |
Clarithromycin appears to be linked with Clostridium difficile-associated diarrhoea in the elderly.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Diarrhea; Female; Humans; Male; Odds Ratio; Prospective Studies; Respiratory Tract Infections; Risk Factors | 2000 |
[Influence of macrolide therapy on microorganism of chronic respiratory tract infections].
Topics: Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Erythromycin; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Respiratory Tract Infections; Roxithromycin; Streptococcus pneumoniae | 2000 |
Clarithromycin and risk of Clostridium difficile-associated diarrhoea.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Clostridioides difficile; Diarrhea; Humans; Respiratory Tract Infections; Risk Factors | 2001 |
[Are the antimicrobials used in community-acquired respiratory infection useful for preventing transmission of meningococcal disease? In vitro study].
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Community-Acquired Infections; Drug Resistance; Fluoroquinolones; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Naphthyridines; Nasopharynx; Neisseria meningitidis; Respiratory Tract Infections; Rifampin; Time Factors | 2001 |
Clarithromycin use preceding fulminant hepatic failure.
Topics: Adult; Clarithromycin; Fatal Outcome; Female; Humans; Kidney Failure, Chronic; Liver Failure; Renal Dialysis; Respiratory Tract Infections; Risk Assessment | 2002 |
Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Chronic Disease; Clarithromycin; Josamycin; Male; Mice; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Pseudomonas Infections; Respiratory Tract Infections | 2002 |
[Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases--the fourth report].
Topics: Adult; Aged; Animals; Chronic Disease; Clarithromycin; Drug Administration Schedule; Drug Evaluation; Erythromycin; Female; Humans; Mice; Middle Aged; Respiratory Tract Infections; Time Factors | 1992 |
Clarithromyocin new approaches to the treatment of respiratory tract infection. Seventh Mediterranean Congress of Chemotherapy. Barcelona, Spain, May 1990.
Topics: Clarithromycin; Erythromycin; Humans; Respiratory Tract Infections | 1991 |
[Clarithromycin in the treatment of respiratory infections].
Topics: Bronchitis; Chronic Disease; Clarithromycin; Erythromycin; Humans; Pneumonia; Respiratory Tract Infections | 1991 |
[Clinical efficacy of clarithromycin].
Topics: Clarithromycin; Erythromycin; Humans; Respiratory Tract Infections; Skin Diseases, Infectious | 1991 |
[Laboratory and clinical studies on clarithromycin in pediatrics].
Topics: Adolescent; Age Factors; Bacteria; Bacterial Infections; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Basic and clinical studies on clarithromycin in pediatrics].
Topics: Age Factors; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Enterocolitis; Erythromycin; Female; Half-Life; Humans; Infant; Infant, Newborn; Male; Respiratory Tract Infections | 1989 |
[Laboratory and clinical studies on clarithromycin in the field of pediatrics].
Topics: Adolescent; Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Experience with clarithromycin in pediatric patients].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Clinical evaluation of clarithromycin in pediatric patients].
Topics: Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Laboratory and clinical studies of clarithromycin in pediatric fields].
Topics: Age Factors; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Neutrophils; Respiratory Tract Infections | 1989 |
[A clinical study on clarithromycin especially on its granular form for children in pediatrics].
Topics: Age Factors; Child; Child, Preschool; Clarithromycin; Colitis; Dosage Forms; Drug Evaluation; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Clinical study of clarithromycin, a new macrolide antibiotic, in children].
Topics: Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Enterocolitis; Erythromycin; Female; Humans; Impetigo; Infant; Male; Respiratory Tract Infections | 1989 |
[Clinical experience with clarithromycin in the pediatric field].
Topics: Administration, Oral; Adolescent; Age Factors; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Erythromycin; Female; Humans; Impetigo; Infant; Male; Respiratory Tract Infections | 1989 |
[Basic and clinical studies on use of clarithromycin granules in pediatrics].
Topics: Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Drug Resistance, Microbial; Enterocolitis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Clinical efficacy of clarithromycin in the field of pediatrics].
Topics: Acute Disease; Administration, Oral; Age Factors; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Enteritis; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
[Clinical observations with clarithromycin in pediatrics].
Topics: Age Factors; Bacteria; Child; Child, Preschool; Clarithromycin; Drug Evaluation; Drug Resistance, Microbial; Enteritis; Erythromycin; Female; Humans; Male; Respiratory Tract Infections | 1989 |
[Pharmacokinetic and clinical studies of clarithromycin in the pediatric field].
Topics: Adolescent; Age Factors; Child; Child, Preschool; Clarithromycin; Dosage Forms; Drug Evaluation; Erythromycin; Female; Humans; Infant; Male; Respiratory Tract Infections | 1989 |
Comparative in vitro activity of A-56268 against respiratory tract pathogens.
Topics: Anti-Bacterial Agents; Clarithromycin; Erythromycin; Haemophilus influenzae; Humans; Moraxella catarrhalis; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes | 1987 |